Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2010 Apr;9(4):333-5.
doi: 10.1016/S1474-4422(10)70055-7. Epub 2010 Feb 26.

Testing the amyloid hypothesis of Alzheimer's disease in vivo

Sam Gandy
Comment

Testing the amyloid hypothesis of Alzheimer's disease in vivo

Sam Gandy. Lancet Neurol. 2010 Apr.
No abstract available

PubMed Disclaimer

Figures

Figure
Figure
Cerebral amyloid plaque visualized with luminescent oligothiophenes. Each color represents a discrete misfolding state of Aβ (Image courtesy of Patrick Hof, Dara Dickstein, Peter Nilsson, and Sam Gandy) (Aslund A, Sigurdson CJ, Klingstedt T, Grathwohl S, Bolmont T, Dickstein DL, Glimsdal E, Prokop S, Lindgren M, Konradsson P, Holtzman DM, Hof PR, Heppner FL, Gandy S, Jucker M, Aguzzi A, Hammarström P, Nilsson KP. Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chem Biol. 2009 Aug 21;4(8):673–84. PubMed PMID: 19624097)
See this image and copyright information in PMC

Comment on

References

    1. Rinne JO, Brooks DJ, Rossor MN, Fox NC, Bullock R, Klunk WE, Mathis CA, Blennow K, Barakos J, Okello AA, de LIano SRM, Liu E, Koller M, Gregg KM, Schenk D, Black R, Grundman M. [11C]PiB PET supports reduced cortical fibrillar Aβ in Alzheimer’s disease patients treated with bapineuzumab. Lancet Neurol. 2010 this issue. - PubMed
    1. Lemere CA, Masliah E. Can Alzheimer disease be prevented by amyloid-beta immunotherapy? Nat Rev Neurol. 2010 Feb;6(2):108–19. - PMC - PubMed
    1. Nicoll JA, Barton E, Boche D, Neal JW, Ferrer I, Thompson P, Vlachouli C, Wilkinson D, Bayer A, Games D, Seubert P, Schenk D, Holmes C. Abeta species removal after abeta42 immunization. J Neuropathol Exp Neurol. 2006 Nov;65(11):1040–8. - PubMed
    1. Swanoski MT. Homotaurine: a failed drug for Alzheimer’s disease and now a nutraceutical for memory protection. Am J Health Syst Pharm. 2009 Nov 1;66(21):1950–3. - PubMed
    1. Green RC, Schneider LS, Amato DA, Beelen AP, Wilcock G, Swabb EA, Zavitz KH. Tarenflurbil Phase 3 Study Group. Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA. 2009 Dec 16;302(23):2557–64. - PMC - PubMed

MeSH terms